The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Aptamer-templated silver nanoclusters embedded in zirconium metal–organic framework for targeted antitumor drug delivery
Abstract
Abstract In this study, we reported a targeted antitumor drug delivery system (DDS) based on the nanocomposite of zirconium metal-organic framework (Zr-MOF, UiO-66) embedded with bioactive silver nanoclusters (Ag NCs) by using AS1411 aptamer (Apt) as the template (denoted by UiO-66@AgNCs@Apt). Targeted antitumor drug delivery system UiO-66@AgNCs@Apt@DOX was also obtained by one-pot encapsulation of antitumor drug doxorubicin (DOX) and formation of Ag NCs, which showed higher DOX loading efficiency and sustained controlled release than the UiO-66@AgNCs@Apt/DOX formed by two separate processes. A proof-of-principle targeting specificity study conducted by confocal laser scanning microscopy reveals that AS1411 aptamer-modified UiO-66@AgNCs@Apt can be effectively taken up and internalized by target cancer cells with high selectivity. In vitro cellular uptake and drug delivery study were further compared for both cancer MCF-7 and normal L929 cells to validate the enhanced tumor-targeted delivery of DOX. The results show that UiO-66@AgNCs@Apt@DOX can be internalized by AS1411-mediated endocytosis, and the released DOX can be effectively delivered to the nucleus, which can serve as in vivo targeted drug delivery system. Cell viability assay illustrates that the synthesized UiO-66@AgNCs@Apt nanocomposite possesses low cytotoxicity to MCF-7 cell in a wide concentration range of 5–50 μg mL −1 , and the drug formulations exhibit good capability for targeted DOX delivery and intracellular controlled release, leading to a robust and enhanced antitumor effect in vitro. These results prove that the proposed AS1411-functionalized UiO-66@AgNCs@Apt@DOX can be a promising targeted drug delivery platform for cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chen, J., Ouyang, J., Chen, Q., Deng, C., Meng, F., Zhang, J., Cheng, R., Lan, Q., & Zhong, Z. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b06879 · Cited by 124
Cited by
Metal–Organic Framework Nanocarriers for Drug Delivery in Biomedical Applications
Sun, Y., Zheng, L., Yang, Y., Qian, X., Fu, T., Li, X., Yang, Z., Yan, H., Cui, C., & Tan, W. (2020) · Nano-Micro Letters · doi:10.1007/s40820-020-00423-3 · Cited by 723
Metal-organic frameworks for stimuli-responsive drug delivery
Wang, Y., Yan, J., Wen, N., Xiong, H., Cai, S., He, Q., Hu, Y., Peng, D., Liu, Z., & Liu, Y. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2019.119619 · Cited by 665
Self-citationMetal-organic frameworks for advanced drug delivery
He, S., Wu, L., Li, X., Sun, H., Xiong, T., Liu, J., Huang, C., Xu, H., Sun, H., Chen, W., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.019 · Cited by 528
Gutiérrez, M., Zhang, Y., & Tan, J.-C. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00980 · Cited by 351
Therapeutic applications of AS1411 aptamer, an update review
Yazdian-Robati, R., Bayat, P., Oroojalian, F., Zargari, M., Ramezani, M., Taghdisi, S. M., & Abnous, K. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.11.118 · Cited by 288
Metadata
- Authors
- Su, F., Jia, Q., Li, Z., Wang, M., He, L., Peng, D., Song, Y., Zhang, Z., & Fang, S.
- Venue
- Microporous and Mesoporous Materials
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 275
- Pages
- 152-162
- ISSN
- 1387-1811 (ISSN-L)
- OpenAlex
- W2888643492
- Cited by
- 179
- References
- 1
- FWCI
- 8.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Aptamer-templated silver nanoclusters embedded in zirconium metal–organic framework for targeted antitumor drug delivery. https://app.cochat.ai/papers/10.1016/j.micromeso.2018.08.026
- The paper
- Su, F., Jia, Q., Li, Z., Wang, M., He, L., Peng, D., Song, Y., Zhang, Z., & Fang, S. (2019). Aptamer-templated silver nanoclusters embedded in zirconium metal–organic framework for targeted antitumor drug delivery. Microporous and Mesoporous Materials. https://doi.org/10.1016/j.micromeso.2018.08.026
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.